Gastric cancer and the epoch of immunotherapy approaches
/in Dendritic Cells, Gastric Cancer, International PublicationsDendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
/in Dendritic Cells, International PublicationsAdvances in the understanding of cancer immunotherapy
/in Dendritic Cells, International PublicationsPrecision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors
/in Dendritic Cells, International PublicationsDendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β
/in Dendritic Cells, International PublicationsDendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
/in Dendritic Cells, International Publications, Multiple MyelomaEngineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions
/in Dendritic Cells, International PublicationsCancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
/in Dendritic Cells, International Publications, Malignant MelanomaDecreased HIV-specific T-regulatory responses are associated with effective DC-vaccine induced immunity
/in Dendritic Cells, HIV/AIDS, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer